Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

• Published in: Psychopharmacology Vol. 121; no. 1; p. 66
• Main Authors: Detke, M J, Rickels, M, Lucki, I
• Format: Journal Article
• Language: English
• Published: Germany 01.09.1995
• Subjects: Animals; Antidepressive Agents - pharmacology; Behavior, Animal - drug effects; Dose-Response Relationship, Drug; Locomotion - drug effects; Male; Motor Activity - drug effects; Norepinephrine - pharmacology; Rats; Rats, Sprague-Dawley; Serotonin - pharmacology
• ISSN: 0033-3158
• DOI: 10.1007/bf02245592

This study demonstrated that distinct patterns of active behaviors are produced by antidepressants that selectively inhibit norepinephrine (NE) or serotonin (5-HT) uptake in the rat forced swimming test (FST). A behavior sampling technique was developed to score the active behaviors swimming, climbing and diving, as well as immobility. The rat's behavior was recorded at the end of each 5-s period during the test session. The sampling technique was both reliable, as demonstrated by test-retest reliability and inter-rater reliability, and valid, as shown by comparison to the timing of behavior durations. Five different antidepressant drugs which block monoamine uptake and two 5-HT1A receptor agonists were shown to decrease immobility in the FST; however, they produced distinct patterns of active behaviors. The selective NE uptake inhibitors desipramine and maprotiline selectively increased climbing, whereas the selective serotonin reuptake inhibitors (SSRIs) fluoxetine, sertraline and paroxetine selectively increased swimming. The 5-HT1A receptor agonists 8-OH-DPAT and gepirone also selectively increased swimming. These results show that:1) SSRIs are not false negatives in the FST; 2) at least two behaviorally distinct processes occur in the FST; and 3) enhancement of NE neurotransmission may mediate climbing in the FST, whereas enhancement of 5-HT neurotransmission may mediate swimming.